Introduction
============

A subset of patients with severe ischemic cardiomyopathy appears to benefit from revascularization. However, the selection of these patients for revascularization is often difficult. On the one hand, there are increased preoperative risks and co-morbidities in these patients, which must be weighed against the potential to improve contractile function, prognosis, and symptoms. This provides the rationale for noninvasive viability testing by using magnetic resonance imaging (MRI). Besides the quantification of myocardial scar tissue using late enhancement ([@b7]; [@b5]), MRI has also been shown to reliably assess the extent of regional myocardial contraction ([@b11]) as well as global volume and function parameters ([@b15]).

Left ventricular (LV) function is among the most important determinants of prognosis in patients with coronary artery disease (CAD) ([@b3]). In patients with ischemic LV dysfunction, CABG is associated with a significant independent reduction in mortality ([@b14]). In the absence of myocardial viability, however, myocardial revascularisation is not associated with any significant difference in outcomes, irrespective of treatment strategy ([@b1]). In CABG patients with preoperative LV dysfunction, MRI hyperenhancement has been shown to reliably indicate myocardial scar tissue ([@b9]). Using magnetic resonance imaging, cardiac function can be assessed globally and regionally ([@b11]). In the present study, we pre- and postoperatively determined global and segmental cardiac function with cardiac MRI. We were therefore interested whether, in addition to an improvement of global myocardial contractility, functional improvement could also be observed on a myocardial segmental basis after CABG surgery.

Material and methods
====================

Patients
--------

Thirty-three patients with a left ventricular ejection fraction ≤30% (as determined by coronary angiography) prospectively underwent MRI scanning before coronary artery bypass grafting (CABG). According to the protocol, the patients were contacted after 18 months and a second MRI scan was performed thereafter. Eventually, of the 33 patients who were scanned preoperatively, 16 underwent postoperative MRI after a mean follow-up of 20 ± 2 months. All patients gave their informed consent, and the study was approved by the institutional ethics committee.

Magnetic resonance imaging
--------------------------

A 1.5 T scanner (Magnetom Sonata, Siemens Medical Solutions, Erlangen, Germany) was used for all MRI examinations. The MRI protocol included a functional study of the left ventricle using an ECG-triggered breath-hold segmented steady-state free precession (SSFP; TrueFISP^®^) cine sequence (TR, 3.0 ms; TE, 1.5 ms, flip angle, 60°) with a slice thickness of 8 mm. After three standard long axes (horizontal and vertical, long axis left ventricular outflow tract), contiguous short axis slices were acquired to cover the entire LV without interslice gap. After injection of 0.2 mmol/kg bw Gd-DTPA (Magnevist™, Schering AG, Berlin, Germany), "late enhancement" (LE) scans were collected in three long and all short axis orientations using a breath-hold ECG-triggered 2D inversion recovery TurboFLASH sequence (TR, 8 ms; TE, 4 ms; flip angle, 25°) as described elsewhere ([@b12]). Images were acquired subsequently 8 to 15 minutes after injection. The inversion time (TI, nonselective inversion pulse) was adjusted manually between 180 and 300 ms to null the signal of normal myocardium. Depending on the field of view (FOV), the typical in-plane resolution was 1.6 × 1.3 mm^2^ for all sequences. Total imaging time including patient positioning was 45--60 minutes.

Image analysis, scoring, and calculating
----------------------------------------

All MRI examinations were interpreted by two radiologists experienced in cardiac MRI by consensus. TrueFISP images were reviewed as cine-loops on a workstation, whereas hardcopies were used for the read-out of the inversion recovery TurboFLASH images. All inversion recovery TurboFLASH data sets in long and short axis orientation were reviewed regarding LE.

Concerning segmental function, standardized myocardial segmentation and nomenclature for tomographic imaging of the heart has been suggested by the American Heart Association. A 17 segment model of the left ventricle was established as well as an assignment of left ventricular myocardial segments to coronary arterial topography ([@b4]). In basal and mid-ventricular portions of the LV, the myocardial circumference was additionally divided into 6 subsegments; in the apical third of the LV, four segments were evaluated plus the apex itself. This resulted in 49 to 61 segments per patient depending on LV dimensions: According to the AHA statement, a mean score was then calculated to assign the scores from all designated short axis images to the individual 17 AHA segments.

The 17 segments were distributed into 3 vessel territories, belonging to the 3 large epicardial arteries left anterior descending (LAD, 7 segments), circumflex artery (Cx, 5 segments) and right coronary artery (RCA, 5 segments). All 17 segments in each patient were assigned one of the major large epicardial arteries. A mean late enhancement score for each of these vessel territories was calculated. Based on the published data by [@b8], dysfunctional segments with LE score 1 or 2 are expected to recover after sufficient revascularization; those segments scored 3 or 4 are considered unlikely to improve function after restitution of perfusion.

A score 1 to 4 system was used to describe the transmural extent of LE in each of the turboFLASH short axis images: Score 1 = no LE; score 2 = subendocardial LE including less than 50% of the wall thickness; score 3 = nontransmural LE including 50% or more of the wall thickness; score 4 = transmural LE ([@b5]). The extent of segmental wall thickening (ie, the degree of wall motion or contractility) of the left ventricle was graded on a five-point scale in which a score of 0 indicated normal function, a score of 1 mild or moderate hypokinesia, a score of 2 severe hypokinesia, a score of 3 akinesia and a score of 4 dyskinesia ([@b8]). Global LV function was assessed by slice summation in end diastole and end systole of the short axis slices after manual planimetry of the endocardial borders using the ARGUS^®^ software (Siemens AG, Munich, Germany).

Surgical management
-------------------

Surgical revascularization was performed as previously described ([@b13]) in all patients using median sternotomy, standard CPB technique with ascending aortic and two-stage venous cannulation. During CPB, moderate hemodilution (hematocrit 20%--25%) with mild systemic hypothermia (\>32 °C) was maintained. Myocardial protection was achieved using antegrade and optional retrograde cold crystalloid (Bretschneider) cardioplegic arrest and additional topical cooling. Patients were postoperatively monitored with respect to arterial pressure, pulmonary pressure, and central venous pressure.

Clinical follow-up
------------------

Patients were contacted 18 months after surgery. The clinical status was assessed using a simple questionnaire.

Statistical analysis
--------------------

Results are expressed as mean ± SEM. For parametric data, differences of means between groups were evaluated using Student's t-test. For categorical data, Fischer's excact test was applied. Differences were considered to be significant with a P value \< 0.05. A possible correlation between intraoperative graft flow and change in myocardial function from before surgery to after surgery was investigated using a bivariate correlation analysis (SPSS 13.0, SPSS Inc., Chicago, Il, USA).

Results
=======

Three patients died perioperatively (hospital mortality 9%), during follow-up one patient died from stroke. Out of the remaining 29 patients, six patients had a contraindication to undergo MRI at the time of follow up because they had received cardiac resynchronization therapy using implantable pacemakers and defibrillators in the meantime. Three patients did not want to undergo MRI again, because they had experienced considerable claustrophobia at the time of the preoperative scan. In three patients, mobility was severely compromized for noncardiac reasons and one patient had moved abroad and was not available for MRI.

[Tables 1](#tbl1){ref-type="table"} and [2](#tbl2){ref-type="table"} show pre-, intra- and postoperative data of the remaining 16 patients. One patient had one vessel disease, one had two vessel disease, all others had three vessel disease. Volume (end systolic and end diastolic volume) and function (left ventricular ejection fraction) parameters, as determined by MRI, significantly improved from before to after surgery ([Figures 1](#fig1){ref-type="fig"} and [2](#fig2){ref-type="fig"}). As an example, [Figure 3](#fig3){ref-type="fig"} shows pre- and postoperative MRI scans. In the respective patient, left ventricular function improved considerably ([Figure 3](#fig3){ref-type="fig"}).

![Volume parameters obtained by using magnetic resonance imaging before (crosshatched bars) and after CABG (hatched bars). Data are mean ± SEM. ESV, Endsystolic volume; EDV, Enddiastolic volume. Numerical values above error bars indicate level of statistical significance between the groups (Student's t-test for unpaired samples).](vhrm0305-763-01){#fig1}

![Left ventricular ejection fraction (LVEF) obtained by using magnetic resonance imaging before and after surgery. Data are mean ± SEM. Numerical value above error bar indicates level of statistical significance between groups (Student's t-test for unpaired samples).](vhrm0305-763-02){#fig2}

![MR Imaging of a 64 year old male before (top line) and after (bottom line) 3-fold CABG. SSFP Cine images in enddiastole (**A**) and endsystole (**B**) reveal the severely impaired global LV function before surgery (EF 30%) with akinesia in the apical inferoseptal and anterolateral wall and the apex (segments 14, 16, and 17) and hypokinesie in the basal and mid-ventricular lateral wall. The contrast-enhanced TurboFLASH image (**C**) shows broad subendocardial late enhancement (bright signal) in the apical septum, thin LE in the lateral wall and transmural LE in the apex meaning chronic scar. LV function after surgery (**D**, **E**) shows no improvement in the apical septum and the apex, whereas the complete lateral wall improved and became normokinetic. No changes in scar extent (**F**). Global LV function improved to EF 40%, LV volumes decreased.](vhrm0305-763-03){#fig3}

###### 

Preoperative patient data

  ----------------------------------- -----------
  Age \[Years\]                       61 ± 3
  Female\[n\]                         0 (0)
  Hypertension \[n\]                  10 (63)
  Hyperlipidemia \[n\]                11 (69)
  Peripheral vascular disease \[n\]   1 (7)
  Atrial fibrillation \[%\]           1 (7)
  Forced expiratory volume \[%\]      76 ± 3
  Serum creatinine \[mg/dL\]          1.2 ± 0.0
  COPD \[n\]                          5 (31)
  Re-operation \[n\]                  1 (7)
  Angiographic LVEF preop \[%\]       26 ± 1
  MRI LVEF preop \[%\]                30 ± 2
  ----------------------------------- -----------

**Note:** Means ± SEM, or number (%).

**Abbreviations:** COPD, Chronic obstructive pulmonary disease; LVEF, Left ventricular ejection fraction.

###### 

Intra- and postoperative patient data

  ------------------------------------------- -----------
  CPB time \[min\]                            106 ± 7
  Aortic cross clamp time \[min\]             67 ± 4
  Distal bypass anastomoses \[n\]             3.7 ± 0.3
  Proximal anastomoses \[n\]                  1.9 ± 0.2
  Maximum postoperative cTnI \[ng/ml\]        9.8 ± 3.8
  Maximum postoperative myoglobin \[ng/ml\]   645 ± 210
  Ventilation time \[h\]                      11 ± 2
  Stay on ICU \[h\]                           70 ± 41
  MRI EF postop \[%\]                         36 ± 3
  ------------------------------------------- -----------

**Note:** Means ± SEM, or number (%).

**Abbreviations:** LVEF, Left ventricular ejection fraction; CPB, Cardiopulmonary bypass; cTnI, cardiac troponin I; ICU, Intensive care unit.

In parallel to global functional improvement, there was functional improvement on a segmental basis. Before surgery, 417 out of 875 segments (48%) in 16 patients showed evidence of late enhancement. 42 segments (4.8%) were classified to be normokinetic (functional score = 0). After surgery, 177 segments (20.4%) were normokinetic (*p* \< 0.05). Of 388 segments preoperatively classified to be severely hypokinetic (functional score = 2), 141 (36.3%) improved by at least one score point. Of 193 segments classified as akinetic before surgery (functional score = 3), 21 segments (10.8%) improved by at least one score point at the time of follow-up.

Myocardial segments assigned to the LAD territory had a mean score of 3.2 ± 0.1 before surgery and a score of 2.8 ± 0.2 at follow up (*p* \< 0.05). Myocardial segments assigned to the circumflex artery had a mean functional score of 3.2 ± 0.2 before and 2.9 ± 0.2 after surgery (*p* = 0.1). Left ventricular myocardial segments assigned to the right coronary artery territory had a mean score of 2.6 ± 0.2 before and 2.4 ± 0.3 after surgery (*p* = 0.10).

There was also significant clinical improvement. Before surgery patients reported a mean NYHA class of 3.0 ± 0.1. Eighteen months after surgery mean NYHA class was 2.2 ± 0.2 (*p* \< 0.01).

Conclusion
==========

In patients with significant coronary artery disease and left ventricular dysfunction, survival after coronary artery bypass grafting has been shown to be better than with medical therapy alone ([@b10]). However, only those patients benefit from surgical revascularisation who displays the presence of dysfunctional but viable myocardium. Patients without viable myocardium do not benefit from myocardial revascularisation, irrespective of treatment strategy ([@b1]). The present study shows favorable results at 20 months follow-up after surgical revascularization. Reverse remodelling of the dysfunctional left ventricle could be demonstrated by an improvement of global and segmental function and patients were in a lower NYHA class.

The transmural extent of hyperenhancement was reported to significantly relate to the likelihood of improvement in contractility after revascularization in a reversed way ([@b8]). Contractility improved in 78% of segments with no hyperenhancement but in only 1 of 58 segments with hyperenhancement of more than 75%. Myocardium that shows transmural late enhancement, which represents scare tissue, is not believed to be improved by revascularisation ([@b7], [@b8]).

The postoperative dropout concerning magnetic resonance follow up scan was considerable because of many reasons (see Results section), so that only 16 of 29 surviving patients could be investigated. Postoperative implantation of defibrillators and pacemakers has been described to lead to a loss of follow up in patients due to undergo postoperative MRI ([@b8]). In recent years, cardiac resynchronization therapy has further increased the indication for pacemaker/defibrillator implantation in patients with compromized left ventricular function.

In conclusion, the present study clearly confirms the results of several recent clinical trials that noninvasive myocardial viability testing with magnetic resonance imaging detect those patients with severely compromized left ventricular function, in whom CABG surgery can significantly improve global left ventricular function ([@b1]; Bax et al 1997). Moreover, the present study could also demonstrate a significant reverse remodelling and improvement of left ventricular function after CABG surgery on a myocardial segmental basis using MRI viability testing. After surgery, left ventricular function improves along with a considerable clinical benefit of the patients.

Limitations
-----------

Our study encompasses the experience at a single tertiary medical center; therefore, the generalizability of our findings may not extend to all of the clinical centers performing CABG. One of the main limitations of the present study is the high drop-out rate during the follow-up period. Only 16 out of 29 surviving patients were eligible for postoperative MRI follow-up because of several limitations and contraindications to undergo MRI scan, having received cardiac resynchronization therapy in the meantime, had claustrophobia, were unavailable or had a severely compromized mobility for noncardiac reasons.
